Abstract
Rivaroxaban is an oral direct Factor Xa inhibitor to treat thrombus. The aim of this study is to investigate the drug–excipient compatibility between rivaroxaban tablet and pharmaceutical excipients by a combination of thermal and spectroscopic methods. Differential scanning calorimetry (DSC) is the most important technique to evaluate the compatibility. In addition, X-ray powder diffraction (XRPD) is a complementary technique to explain the DSC result and exclude relevant interaction. On the basis of DSC curves about rivaroxaban and excipient and mixture (1:1, w/w), the rivaroxaban was considered to be compatible with the most excipients (microcrystalline cellulose, lactose, hydroxyl propyl methyl cellulose, magnesium stearate). Meanwhile, the XRPD studies also showed the compatibility of rivaroxaban and pharmaceutical excipients, especially for the sodium lauryl sulfate. Overall, the compatibility of the excipients with rivaroxaban was assessed successfully by DSC and XRPD, and the formulations developed using the compatible excipient were found to be stable.
Similar content being viewed by others
References
Kubitza DD, Becka DM, Mueck DW, et al. Safety, tolerability, pharmacodynamics, and pharmacokinetics of Rivaroxaban-an oral, direct factor Xa inhibitor-are not affected by Aspirin. J Clin Pharmacol. 2006;46:981–90.
Roehrig S, Straub A, Pohlmann J, et al. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-ylmethyl)thiophene-2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor. J Med Chem. 2005;48:5900–8.
Grunenberg A, Fähnrich K, Queckenberg O, et al. Co-crystal compound of rivaroxaban and malonic acid. US, US 8466280 B2. 2013.
Li DX, Ke H, Fan XB, et al. A new crystal form of rivaroxaban and preparation method and use. CN, CN104211693A. 2014.
Gamini V, Prabhudas B. Polymorphic form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1, 3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide. CN, CN102292332 A. 2011.
Gao R, Jin Y, Yang QY, et al. Study of stability and drug–excipient compatibility of estradiol and pharmaceutical excipients. J Therm Anal Calorim. 2015;120:839–45.
Matos APS, Costa JS, Boniatti J, et al. Compatibility study between diazepam and tablet excipients. J Therm Anal Calorim. 2016; 1–8.
Gao R, Sun BW, Lin J, et al. Compatibility of medroxyprogesterone acetate and pharmaceutical excipients through thermal and spectroscopy techniques. J Therm Anal Calorim. 2014;117:731–9.
Narang AS, Yamniuk A, Zhang L, et al. Drug excipient interactions. In: AS Narang, SHS Boddu, editors. Excipient applications in formulation design and drug delivery. Springer; 2015. p. 13–35.
Wang Y, Luo YH, Zhao J, Sun BW. Selection of excipients for dispersible tablets of itraconazole through the application of thermal techniques and Raman spectroscopy. J Therm Anal Calorim. 2013;115:2391–400.
Luo YH, Wen GJ, Gu LS, et al. Study of spin crossover in an iron(II) tris(diimine) system tuned by counter anions. Polyhedron. 2017;121:101–6.
Luo YH, Wu DE, Wen GJ, et al. A two-dimensional supramolecular ice layer containing “Quasi-Chair” (H2 O)6 hexagons templated by organic carboxylic host. ChemistrySelect. 2017;2:61–4.
Stulzer HK, Rodrigues PO, Cardoso TM, et al. Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations. J Therm Anal Calorim. 2008;91:323–8.
Groom Nanboge A, Lentz J, Braun GA, Kell B, Thomas CR. New crystal forms and amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1, 3-oxazolidin-5-ylmethyl) thiophene-2-carboxamide. Publish No: CN101282968.
Kandarapu R, Grover V, Chawla HPS, et al. Evaluation of compatibility of ketorolac tromethamine with selected polymers and common tablet excipients by thermal and isothermal stress testing. Stp Pharma Sci. 2001;11:449–57.
Mura P, Manderioli A, Bramanti G, et al. Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients. Int J Pharm. 1995;119:71–9.
Araújo AAS, Storpirtis S, Mercuri LP, et al. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms[J]. Int J Pharm. 2003;260:303–14.
Lima NGPB, Lima IPB, Barros DMC, et al. Compatibility studies of trioxsalen with excipients by DSC, DTA, and FTIR. J Therm Anal Calorim. 2014;115:2311–8.
Acknowledgements
This research was based on work supported by the Technological Program Foundation of Jiangsu Province (No. BY2015070-09) and PAPD of Jiangsu Higher Education Institutions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ding, T., Chen, L., Zhai, LH. et al. Compatibility study of rivaroxaban and its pharmaceutical excipients. J Therm Anal Calorim 130, 1569–1573 (2017). https://doi.org/10.1007/s10973-017-6412-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-017-6412-3